HRD-Directed Therapeutics Hold Potential in Breast Cancer, But Challenges Remain
OncLive,
Chris Lord, MD Tumors exhibiting homologous recombination deficiency (HRD) have traditionally been treated with targeted…
Chris Lord, MD Tumors exhibiting homologous recombination deficiency (HRD) have traditionally been treated with targeted…
Turbine delivering AI-powered oncology pipeline for PARP resistance and other unmet needs Turbine backed by leading science and…
- Turbine delivering AI-powered oncology pipeline for PARP resistance and other unmet needs- Turbine backed by leading science…
- Turbine delivering AI-powered oncology pipeline for PARP resistance and other unmet needs - Turbine backed by leading science…